Quantinuum completed one of the largest quantum-computing initial public offerings (IPOs) to date, listing on Nasdaq on June 5, 2026, at $60 per share and raising $1.68 billion, backed by Honeywell International (HON).
For this article, roughly a dozen attributable, current analyst price targets were reviewed. They include Rosenblatt Securities ($155, John McPeake), Needham ($100), Craig-Hallum ($100, Richard Shannon), Evercore ISI ($98), J.P. Morgan ($97), Bernstein ($95, Mark Moerdler), Mizuho ($90), Cantor Fitzgerald ($90, Troy Jensen), Jefferies ($85, Kevin Garrigan), Morgan Stanley ($78, a Hold), and Yorkville Ives ($60, Daniel Ives). The low-to-high range runs from $60 to $155, and the arithmetic mean of these targets is approximately $95.
That range is unusually wide, reflecting genuine disagreement. Bulls argue that the company's trapped-ion hardware, growing bookings, and the Sol (2027) and Apollo (2029) systems justify a premium; more cautious desks emphasize steep losses, a still-tiny revenue base, and rich multiples. Independent aggregators, using slightly different samples, report average targets near $97 to $98, but the $95 figure here is the mean of the individually verified targets, not an official published consensus.
Quantinuum shares recently closed near $36.76, well below the $60 IPO price and roughly 58% under their July 2026 intraday high of about $86.79. Reaching $95 would require an advance of approximately 158%, which is a very large move for a company with a market capitalization already in the high single-digit billions.
The path would depend less on near-term profitability and more on commercial inflection. In its first quarter as a public company, revenue rose 279% year over year to about $8 million, with full-year guidance of $28 million to $32 million. Management has pointed to a path of more than 100% revenue growth in 2027. However, the company is unprofitable and missed quarterly earnings expectations by $0.02 per share (EPS), underscoring that losses remain large relative to revenue.
The stock is in a sharp post-IPO downtrend, recently trading near its 52-week low of about $36.32, which now acts as near-term support; a break below that level would leave limited chart support from the brief public trading history. Overhead, the $40s represent the first resistance zone, followed by the psychological $60 IPO level and the July high near $86.79. Reaching $95 would require clearing all of these levels and reclaiming territory the stock has not held since shortly after its debut.
Analyst price targets generally reflect a research horizon of about 12 months, though firms do not always state this explicitly and timelines can differ. Investors should watch quarterly earnings and bookings updates, any changes to 2026 or 2027 revenue guidance, progress milestones on Sol and Apollo, analyst revisions, and broader rate and sector conditions that influence high-multiple growth stocks.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor positions, and spot changing trends more efficiently than manual screening. For a volatile name like Quantinuum, pairing fundamental research with a systematic, AI-assisted signal can add a useful second layer of perspective on short-term momentum and risk.
The $95 target is an average of the verified analyst price targets reviewed here, spanning a wide $60 to $155 range that itself reflects how much genuine disagreement exists around this early-stage, loss-making quantum-computing company. From roughly $36.76, reaching that level would require a very large gain of about 158%. The strongest supports are bookings momentum and a clearly defined hardware roadmap, while the principal obstacles are steep losses, a small revenue base, execution risk, and a rich valuation. Whether Quantinuum approaches $95 will depend on converting bookings into revenue and hitting its Sol and Apollo milestones — outcomes no one can guarantee.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.